| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $115M | — | — | — | — |
| Op. Income | $15M | — | — | — | — |
| Gross Margin | 73.6% | — | — | — | — |
| Net Margin | 13.6% | — | — | — | — |
| EPS (Diluted) | $0.06 | — | — | — | — |
| Free Cash Flow | $29M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $115M |
| Cost of Revenue | $30M |
| GROSS PROFIT | $84M |
| R&D Expenses | $13M |
| Selling & Marketing | $38M |
| General & Administrative | $19M |
| SG&A Expenses | $57M |
| Other Expenses | $0 |
| Operating Expenses | $70M |
| Cost & Expenses | $100M |
| OPERATING INCOME | $15M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $1M |
| INCOME BEFORE TAX | $16M |
| Income Tax Expense | $323.0K |
| Net Income from Continuing Ops | $16M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $16M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $16M |
| D&A | $2M |
| EBIT | $0 |
| EBITDA | $2M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $115M |
| Cost of Revenue | $30M |
| GROSS PROFIT | $84M |
| R&D Expenses | $13M |
| Selling & Marketing | $38M |
| General & Administrative | $19M |
| SG&A Expenses | $57M |
| Other Expenses | $0 |
| Operating Expenses | $70M |
| Cost & Expenses | $100M |
| OPERATING INCOME | $15M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $1M |
| INCOME BEFORE TAX | $16M |
| Income Tax Expense | $323.0K |
| Net Income from Continuing Ops | $16M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $16M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $16M |
| D&A | $2M |
| EBIT | $0 |
| EBITDA | $2M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $16M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $8M |
| Deferred Income Tax | $1M |
| Other Non-Cash Items | $352M |
| Change in Working Capital | -$349M |
| OPERATING CASH FLOW | $30M |
| Capital Expenditure | -$697.0K |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$27.0K |
| Sales/Maturities of Investments | $27.0K |
| Other Investing Activities | $12M |
| NET CASH FROM INVESTING | $11M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$22M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$31M |
| NET CASH FROM FINANCING | -$31M |
| FREE CASH FLOW | $29M |
| Net Change in Cash | $9M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $481M |
| Short-Term Investments | $0 |
| Net Receivables | $125M |
| Inventory | $0 |
| Other Current Assets | $20M |
| TOTAL CURRENT ASSETS | $625M |
| PP&E (Net) | $23M |
| Goodwill | $38M |
| Intangible Assets | $12M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $91M |
| TOTAL NON-CURRENT ASSETS | $164M |
| TOTAL ASSETS | $789M |
| Account Payables | $4M |
| Short-Term Debt | $0 |
| Deferred Revenue | $186M |
| Other Current Liabilities | $84M |
| TOTAL CURRENT LIABILITIES | $274M |
| Long-Term Debt | $10M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $27M |
| TOTAL NON-CURRENT LIABILITIES | $37M |
| TOTAL LIABILITIES | $310M |
| Common Stock | $22.0K |
| Additional Paid-In Capital | $0 |
| Retained Earnings | -$510M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $8M |
| Other Equity | $980M |
| TOTAL STOCKHOLDERS' EQUITY | $479M |
| Minority Interest | $0 |
| TOTAL EQUITY | $479M |
| TOTAL LIABILITIES & EQUITY | $789M |
| Total Debt | $10M |
| Net Debt | -$471M |
